🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06434298
Enrolling by invitation Not applicable

Provincial Scale-up of Choose to Move (CTM) Phase 4

NCT06434298 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2023-09-01
Last updated
2024-06-06

Condition(s) studied

AgingPhysical InactivityMobility LimitationLonelinessSocial Isolation

Investigational drug(s) / intervention(s)

Choose to Move

Choose to Move: As described under study arm description

Study summary

Choose to Move (CTM) is a 3-month, choice-based health-promoting program for low active older adults being scaled-up across British Columbia (BC), Canada. In this project, the investigators will expand delivery of the optimized Phase 4 program with large and small partner organizations and will describe and assess scale-up, implementation, and impact of CTM Phase 4.

Eligibility

Sex
ALL
Min age
50 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Central support unit staff member * Activity coach hired by delivery partner organization (activity coaches must speak English to participate in the evaluation); * English-speaking older adults (aged \>=50 years) who participate in CTM (recruited by delivery partner organizations) will be invited to participate in the evaluation; * Non-English speaking older adults will also be invited to participate in the evaluation as long as an intermediary who has the necessary language skills to ensure effective communication/translation of the consent and surveys is present. Exclusion Criteria: * None

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centre for Hip Health and Mobility, Robert H.N. Ho Research Centre, University of British Columbia Vancouver British Columbia

More University of British Columbia trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06434298 on ClinicalTrials.gov ↗ ← All trials in Canada